Close Menu

gene expression

Researchers from the Netherlands have uncovered a new gene expression signature linked to ovarian cancer survival that is providing hints about potential pathways of importance for the disease. But authors warn that using such signatures for guiding treatment may be a ways off.

Affy aims to target downstream genomic-analysis markets with the products gained through its acquisitions of Panomics and True Materials last year, roll out new genotyping assays on its GeneTitan array platform, and consolidate its manufacturing facilities.

The activities are part of Kreatech's makeover from a biotech specializing in FISH probes and labeling kits, to a molecular diagnostics company with expertise in oncology, hematology, and constitutional disorders.

Short Reads: Feb 3, 2009

Premium

Broad Institute, Expression Analysis, Helicos BioSciences, University of Texas at Austin, Applied Biosystems, University of Georgia, ABRF, Genomatix, Illumina, Mondobiotech, 23andMe, Kapa Biosystems

New Products: Feb 3, 2009

Premium

CLC Genomics Workbench 3.0, CAMERA 1.3.2.28

Genotyping Tech Guide

Premium

Genome Technology Genotyping Tech Guide

A team of Ontario researchers has identified a six-gene signature that can help predict non-small cell lung cancer outcomes — and uncovered evidence that there may be thousands of alternative prognostic signatures for the disease.

Roche will use Response Genetics' technology to assess a HER2 expression test.

The Realm of Noncoding RNAs

Premium

Small (and not-so-small) noncoding RNAs have thrown a spanner in the works of understanding genome function. We take a look at the major questions brought about by micro-RNA, Piwi-interacting RNA, and more.

A Whole New System

Premium

Now in its ninth year, the experiment that was the Institute for Systems Biology has become an established research organization known for its focus on translational science.

Pages

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.